|
1
|
Rao NA, Gupta A, Dustin L, Chee SP, Okada
AA, Khairallah M, Bodaghi B, Lehoang P, Accorinti M, Mochizuki M,
et al: Frequency of distinguishing clinical features in
Vogt-Koyanagi-Harada disease. Ophthalmology. 117:591–599.
599.e12010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang P, Zhong Y, Du L, Chi W, Chen L,
Zhang R, Zhang M, Wang H, Lu H, Yang L, et al: Development and
evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease.
JAMA Ophthalmol. 136:1025–1031. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
O'Keefe GA and Rao NA:
Vogt-Koyanagi-Harada disease. Surv Ophthalmol. 62:1–25. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patil YB, Garg R, Rajguru JP, Sirsalmath
M, Bevinakatti VA, Kumar M and Sharma S: Vogt-Koyanagi-Harada (VKH)
syndrome: A new perspective for healthcare professionals. J Family
Med Prim Care. 9:31–35. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Turula H and Wobus CE: The role of the
polymeric immunoglobulin receptor and secretory immunoglobulins
during mucosal infection and immunity. Viruses. 10:2372018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ajmi H, Mabrouk S, Hassayoun S, Regaieg H,
Tfifha M, Jalel C, Skouri H, Zouari N and Abroug S: Success of
anti-CD20 monoclonal antibody treatment for severe autoimmune
hemolytic anemia caused by warm reactive immunoglobulin A,
immunoglobulin G, and immunoglobulin M autoantibodies in a child: A
case report. J Med Case Rep. 11:3212017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wyatt RJ and Julian BA: IgA nephropathy. N
Engl J Med. 368:2402–2414. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pape S, Schramm C and Gevers TJ: Clinical
management of autoimmune hepatitis. United European Gastroenterol
J. 7:1156–1163. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smolen JS, Aletaha D and McInnes IB:
Rheumatoid arthritis. Lancet. 388:2023–2038. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sanjuan MA, Sagar D and Kolbeck R: The
role of IgE in autoimmunity. J Allergy Clin Immunol. 137:1651–1661.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Messingham KA, Holahan HM and Fairley JA:
Unraveling the significance of IgE autoantibodies in organ-specific
autoimmunity: Lessons learned from bullous pemphigoid. Immunol Res.
59:273–278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Romero MD, Muiño JC, Bianco GA, Ferrero M,
Juarez CP, Luna JD and Rabinovich GA: Circulating anti-galectin-1
antibodies are associated with the severity of ocular disease in
autoimmune and infectious uveitis. Invest Ophthalmol Vis Sci.
47:1550–1556. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Muiño JC, Juárez CP, Luna JD, Castro CC,
Wolff EG, Ferrero M and Romero-Piffiguer MD: The importance of
specific IgG and IgE autoantibodies to retinal S antigen, total
serum IgE, and sCD23 levels in autoimmune and infectious uveitis. J
Clin Immunol. 19:215–222. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gupta V, Gupta P, Singh R, Dogra MR and
Gupta A: Spectral-domain Cirrus high-definition optical coherence
tomography is better than time domain stratus optical coherence
tomography for evaluation of macular pathologic features in
uveitis. Am J Ophthalmol. 145:1018–1022. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He JS, Narayanan S, Subramaniam S, Ho WQ,
Lafaille JJ and Curotto de Lafaille MA: Biology of IgE production:
IgE cell differentiation and the memory of IgE responses. Curr Top
Microbiol Immunol. 388:1–19. 2015.PubMed/NCBI
|
|
16
|
Turqueti-Neves A, Otte M, Prazeres da
Costa O, Höpken UE, Lipp M, Buch T and Voehringer D:
B-cell-intrinsic STAT6 signaling controls germinal center
formation. Eur J Immunol. 44:2130–2138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J, Liu N and Zhang M: The detection
results of total IgE in patients with different types of diseases.
Labeled Immunoassays Clin Med. 26:1452–1460. 2019.(In Chinese).
|
|
18
|
Cozzani E, Gasparini G, Di Zenzo G and
Parodi A: Immunoglobulin E and bullous pemphigoid. Eur J Dermatol.
28:440–448. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Atta AM, Sousa CP, Carvalho EM and
Sousa-Atta MLB: Immunoglobulin E and systemic lupus erythematosus.
Braz J Med Biol Res. 37:1497–1501. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lamb PM, Patton T and Deng JS: The
predominance of IgG4 in prodromal bullous pemphigoid. Int J
Dermatol. 47:150–153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Permin H and Wiik A: The prevalence of IgE
antinuclear antibodies in rheumatoid arthritis and systemic lupus
erythematosus. Acta Pathol Microbiol Scand C. 86C:245–249.
1978.PubMed/NCBI
|
